V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038847 | 210006765 | null | 72 | Curative (C) | 2019-01-10 | 2019-04-11 | ALL UKALL2003 TRIAL | N | N | 210010978 | UKALL 2003 |
| 210038848 | 210006849 | 0 | 52.3 | Disease modification (D) | 2018-05-29 | 2018-07-24 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | 210011203 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210038849 | 210007179 | null | 69.3 | Disease modification (D) | 2018-12-13 | 2019-03-01 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210012572 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210038850 | 210007596 | 1.7 | 37.3 | Curative (C) | 2020-04-18 | 2020-05-02 | Venetoclax | 02 | N | 210013640 | VENETOCLAX |
| 210038851 | 210007731 | null | 58.7 | Curative (C) | 2015-02-24 | 2015-08-23 | Etoposide Conditioning | N | N | 210013914 | ETOPOSIDE |
| 210038853 | 210008140 | 1.85 | 89.6 | Curative (C) | 2015-12-04 | 2015-12-05 | CARBOPLATIN + ETOPOSIDE | N | N | 210014747 | ERWINIA ASPARAGINASE |
| 210038855 | 210012159 | 1.81 | null | Curative (C) | 2017-04-03 | 2017-06-22 | BR14 TRIAL | 2 | N | 210033375 | PACLITAXEL |
| 210038856 | 210013419 | 1.7 | 50.35 | Curative (C) | 2019-09-02 | 2019-10-10 | IDARUBICIN | N | N | 210040628 | ALL MAINTENANCE |
| 210038857 | 210022612 | 1.71 | 85.2 | Curative (C) | 2018-08-14 | 2018-08-17 | RCEOP | N | N | 210028705 | ALEMTUZUMAB + CYCLOPHOSPHAMIDE |
| 210038858 | 210038852 | 1.69 | null | Adjuvant (A) | 2020-01-04 | 2020-01-06 | Temozolomide 150mg/m2 | N | N | 210002777 | TEMOZOLOMIDE |
| 210038859 | 210036703 | null | 16.1 | Curative (C) | 2019-09-26 | 2019-12-27 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | N | 210004002 | UKALL2011 |
| 210038860 | 210005257 | 0 | 40.4 | Curative (C) | null | 2019-11-06 | ALL UKALL2011 Maintenance A1 | Y | null | 210005410 | UKALL2011 |
| 210038862 | 210005428 | 0.97 | 19.4 | Curative (C) | 2015-06-02 | 2016-04-01 | ALL UKALL2011 Maintenance A1 | Y | N | 210006133 | UKALL2011 |
| 210038863 | 210025157 | null | null | Curative (C) | 2016-09-16 | 2016-11-25 | ALL UKALL2011 Std Int Maint A | Y | null | 210006602 | UKALL2011 |
| 210038866 | 210005709 | 0 | 15.1 | Curative (C) | 2018-05-10 | 2019-02-08 | ALL UKALL2011 TRIAL | Y | N | 210007468 | UKALL 2011 |
| 210038867 | 210005761 | null | 18.7 | Curative (C) | 2016-01-29 | 2016-05-13 | ALL UKALL2011 Std Int Maint B | Y | N | 210007627 | UKALL 2011 |
| 210038868 | 210005850 | null | 48.7 | Curative (C) | 2015-09-04 | 2016-02-21 | ALL UKALL2011 Maintenance A2 | Y | N | 210007896 | UKALL 2011 |
| 210038869 | 210032861 | null | 74 | Curative (C) | 2014-03-26 | 2014-11-18 | Methotrexate Intrathecal (any age) | Y | N | 210008060 | METHOTREXATE INTRATHECAL |
| 210038871 | 210029999 | 0 | 21 | Curative (C) | 2017-10-11 | 2017-10-15 | Methotrexate intrathecal | N | N | 210008355 | METHOTREXATE INTRATHECAL |
| 210038872 | 210006007 | 1.13 | 43.3 | Curative (C) | 2017-07-28 | 2017-08-21 | Methotrexate intrathecal | N | N | 210008484 | METHOTREXATE INTRATHECAL |
| 210038874 | 210018154 | 1.85 | 69.1 | Curative (C) | 2012-03-16 | 2015-02-26 | UKALL14- Intens/CNS Proph | 2 | N | 210008769 | UKALL2014 |
| 210038875 | 210006103 | null | 68.2 | Curative (C) | 2016-05-17 | 2016-08-13 | UKALL14- Maintenance | Y | N | 210008823 | UKALL2014 |
| 210038876 | 210006116 | 1.85 | 93.4 | Curative (C) | 2020-04-27 | 2020-05-20 | UKALL14- Cons Cycle 2 | Y | Y | 210008880 | UKALL2014 |
| 210038877 | 210006223 | 1.69 | 81.2 | Curative (C) | 2017-01-19 | 2017-05-11 | UKALL14- Intens/CNS Proph | Y | N | 210009402 | UKALL2014 |
| 210038878 | 210006299 | 1.7 | 81.2 | Curative (C) | 2017-02-20 | 2017-06-28 | UKALL14- Ph 2 Induction | Y | null | 210009764 | UKALL2014 |
| 210038879 | 210006307 | 0 | 54.3 | Curative (C) | 2014-07-16 | 2014-07-22 | CNS Epen2007 09 Baby Brn cisplatin | N | N | 210009769 | NOT MATCHED |
| 210038880 | 210006339 | 0 | 34.8 | Adjuvant (A) | 2017-08-08 | 2017-09-25 | CNS Epen2007 09 Baby Brn vinc+Mtx | N | N | 210009828 | NOT MATCHED |
| 210038881 | 210006347 | 1.47 | 69.6 | Palliative (P) | 2016-09-01 | 2016-09-01 | PCV | N | N | 210009833 | PCV |
| 210038882 | 210006422 | 1.51 | 77.9 | Disease modification (D) | 2016-12-13 | 2016-12-15 | Rituximab | 02 | N | 210010026 | RITUXIMAB |
| 210038884 | 210006724 | 1.77 | 71.2 | Disease modification (D) | 2015-06-27 | 2015-08-08 | ALL UKALL60+ TRIAL | Y | N | 210010917 | UKALL60+ |
| 210038885 | 210006766 | null | 72.9 | Curative (C) | 2019-10-02 | 2019-10-02 | CHOP R - 21 days | 2 | N | 210010978 | CHOP R |
| 210038886 | 210007596 | null | 75.3 | Curative (C) | 2018-12-13 | 2020-06-13 | Erwinase (Erwinia Asparaginase) | Y | N | 210013640 | RIALTO TRIAL |
| 210038888 | 210013419 | null | null | Curative (C) | 2019-10-22 | 2019-10-22 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE | N | N | 210040628 | ICE |
| 210038889 | 210038852 | 1.66 | 49.2 | Adjuvant (A) | 2020-02-13 | 2020-02-13 | Temozolomide 200mg/m2 | N | N | 210002777 | TEMOZOLOMIDE |
| 210038890 | 210004980 | 0 | 20.7 | Curative (C) | 2018-03-19 | 2019-03-22 | ALL UKALL 2011 HD MtxB (Protocol M) | Y | N | 210004002 | UKALL2011 |
| 210038893 | 210017898 | null | 13.3 | Curative (C) | 2018-07-19 | 2019-03-08 | ALL UKALL2011 Maintenance A1 | Y | N | 210007468 | UKALL2011 |
| 210038894 | 210005761 | 1.04 | 17.5 | Curative (C) | 2016-03-17 | 2016-06-03 | ALL UKALL 2011 HD MtxA (Protocol M) | N | N | 210007627 | UKALL 2011 |
| 210038895 | 210032843 | null | 39 | Adjuvant (A) | 2015-12-13 | 2016-02-23 | Methotrexate Intrathecal (any age) | Y | N | 210007896 | METHOTREXATE INTRATHECAL |
| 210038896 | 210034714 | null | 22.25 | Curative (C) | 2014-12-17 | 2014-12-24 | Methotrexate Intrathecal (any age) | Y | N | 210008060 | METHOTREXATE INTRATHECAL |
| 210038898 | 210029999 | null | 69 | Curative (C) | 2017-06-02 | 2017-10-15 | Methotrexate Intrathecal (any age) | Y | N | 210008355 | METHOTREXATE INTRATHECAL |
| 210038899 | 210006007 | 1.72 | 90 | Curative (C) | 2017-06-09 | 2017-08-25 | UKALL14- Cons Cycle 1 | N | N | 210008484 | UKALL2014 |
| 210038901 | 210006090 | 1.69 | null | Curative (C) | 2014-10-30 | 2015-03-04 | UKALL14- Intens/CNS Proph | Y | N | 210008769 | UKALL2014 |
| 210038902 | 210018165 | null | 0 | Curative (C) | 2015-11-26 | 2016-08-20 | CNS Infant MBL Car/Etop | Y | N | 210008823 | NOT MATCHED |
| 210038903 | 210006224 | 0 | 18.7 | Palliative (P) | 2017-02-09 | 2017-05-11 | CNS Medbl Std Risk Maint Carbo | 2 | N | 210009402 | NOT MATCHED |
| 210038904 | 210006299 | 1.52 | null | Palliative (P) | 2017-09-05 | 2017-09-14 | IBRUTINIB | N | null | 210009764 | IBRUTINIB |
| 210038905 | 210006307 | null | 86 | Palliative (P) | 2014-03-05 | 2014-12-27 | Lomustine | 2 | N | 210009769 | LOMUSTINE |
| 210038906 | 210006339 | 1.54 | 52.7 | Disease modification (D) | 2017-07-09 | 2017-12-01 | ALL UKALL2003 TRIAL | N | N | 210009828 | UKALL 2003 |
| 210038908 | 210006724 | null | 58.2 | Curative (C) | 2016-02-02 | 2016-05-02 | Pentostatin | Y | N | 210010917 | IDELALISIB |
| 210038909 | 210006766 | 1.81 | null | Curative (C) | 2019-03-22 | 2019-10-02 | Fluorouracil96hr infusion+RT(3g/m2) | N | null | 210010978 | DOCETAXEL |
| 210038910 | 210007597 | 1.72 | null | Curative (C) | 2020-04-11 | 2020-07-12 | Irinotecan + Temozolomide | Y | N | 210013640 | DOXORUBICIN |